Patient Treatment

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 1441938 Experts worldwide ranked by ideXlab platform

Catherine Carr - One of the best experts on this subject based on the ideXlab platform.

  • association of Patient Treatment preference with dropout and clinical outcomes in adult psychosocial mental health interventions a systematic review and meta analysis
    JAMA Psychiatry, 2020
    Co-Authors: Emma Windle, Helena Tee, Alina Sabitova, Nikolina Jovanovic, Stefan Priebe, Catherine Carr
    Abstract:

    Importance Receiving a preferred Treatment has previously been associated with lower dropout rates and better clinical outcomes, but this scenario has not been investigated specifically for psychosocial interventions for Patients with a mental health diagnosis. Objective To assess the association of Patient Treatment preference with dropout and clinical outcomes in adult psychosocial mental health interventions via a systematic review and meta-analysis. Data Sources The Cochrane Library, Embase, PubMed, PsychINFO, Scopus, Web of Science, Nice HDAS (Healthcare Databases Advanced Search), Google Scholar, BASE (Bielefeld Academic Search Engine), Semantic Scholar, and OpenGrey were searched from inception to July 20, 2018, and updated on June 10, 2019. Study Selection Studies were eligible if they (1) were a randomized clinical trial; (2) involved participants older than 18 years; (3) involved participants with mental health diagnoses; (4) reported data from a group of participants who received their preferred Treatment and a group who received their nonpreferred Treatment or who were not given a choice; and (5) offered at least 1 psychosocial intervention. Data Extraction and Synthesis Two researchers extracted study data for attendance, dropout, and clinical outcomes independently. Both assessed the risk of bias according to the Cochrane tool. Data were pooled using random-effects meta-analyses. Main Outcomes and Measures The following 7 outcomes were examined: attendance, dropout, therapeutic alliance, depression and anxiety outcomes, global outcomes, Treatment satisfaction, and remission. Results A total of 7341 articles were identified, with 34 eligible for inclusion. Twenty-nine articles were included in the meta-analyses comprising 5294 participants. Receiving a preferred psychosocial mental health Treatment had a medium positive association with dropout rates (relative risk, 0.62; 0.48-0.80;P  Conclusions and Relevance This is the first review, to our knowledge, examining the association of receiving a preferred psychosocial mental health Treatment with both engagement and outcomes for Patients with a mental health diagnosis. Patients with mental health diagnoses who received their preferred Treatment demonstrated a lower dropout rate from Treatment and higher therapeutic alliance scores. These findings underline the need to accommodate Patient preference in mental health services to maximize Treatment uptake and reduce financial costs of premature dropout and disengagement.

Carr C - One of the best experts on this subject based on the ideXlab platform.

  • Association of Patient Treatment Preference With Dropout and Clinical Outcomes in Adult Psychosocial Mental Health Interventions: A Systematic Review and Meta-analysis.
    'American Medical Association (AMA)', 2019
    Co-Authors: Windle E, Tee H, Sabitova A, Jovanovic N, Priebe S, Carr C
    Abstract:

    Importance: Receiving a preferred Treatment has previously been associated with lower dropout rates and better clinical outcomes, but this scenario has not been investigated specifically for psychosocial interventions for Patients with a mental health diagnosis. Objective: To assess the association of Patient Treatment preference with dropout and clinical outcomes in adult psychosocial mental health interventions via a systematic review and meta-analysis. Data Sources: The Cochrane Library, Embase, PubMed, PsychINFO, Scopus, Web of Science, Nice HDAS (Healthcare Databases Advanced Search), Google Scholar, BASE (Bielefeld Academic Search Engine), Semantic Scholar, and OpenGrey were searched from inception to July 20, 2018, and updated on June 10, 2019. Study Selection: Studies were eligible if they (1) were a randomized clinical trial; (2) involved participants older than 18 years; (3) involved participants with mental health diagnoses; (4) reported data from a group of participants who received their preferred Treatment and a group who received their nonpreferred Treatment or who were not given a choice; and (5) offered at least 1 psychosocial intervention. Data Extraction and Synthesis: Two researchers extracted study data for attendance, dropout, and clinical outcomes independently. Both assessed the risk of bias according to the Cochrane tool. Data were pooled using random-effects meta-analyses. Main Outcomes and Measures: The following 7 outcomes were examined: attendance, dropout, therapeutic alliance, depression and anxiety outcomes, global outcomes, Treatment satisfaction, and remission. Results: A total of 7341 articles were identified, with 34 eligible for inclusion. Twenty-nine articles were included in the meta-analyses comprising 5294 participants. Receiving a preferred psychosocial mental health Treatment had a medium positive association with dropout rates (relative risk, 0.62; 0.48-0.80; P 

Emma Windle - One of the best experts on this subject based on the ideXlab platform.

  • association of Patient Treatment preference with dropout and clinical outcomes in adult psychosocial mental health interventions a systematic review and meta analysis
    JAMA Psychiatry, 2020
    Co-Authors: Emma Windle, Helena Tee, Alina Sabitova, Nikolina Jovanovic, Stefan Priebe, Catherine Carr
    Abstract:

    Importance Receiving a preferred Treatment has previously been associated with lower dropout rates and better clinical outcomes, but this scenario has not been investigated specifically for psychosocial interventions for Patients with a mental health diagnosis. Objective To assess the association of Patient Treatment preference with dropout and clinical outcomes in adult psychosocial mental health interventions via a systematic review and meta-analysis. Data Sources The Cochrane Library, Embase, PubMed, PsychINFO, Scopus, Web of Science, Nice HDAS (Healthcare Databases Advanced Search), Google Scholar, BASE (Bielefeld Academic Search Engine), Semantic Scholar, and OpenGrey were searched from inception to July 20, 2018, and updated on June 10, 2019. Study Selection Studies were eligible if they (1) were a randomized clinical trial; (2) involved participants older than 18 years; (3) involved participants with mental health diagnoses; (4) reported data from a group of participants who received their preferred Treatment and a group who received their nonpreferred Treatment or who were not given a choice; and (5) offered at least 1 psychosocial intervention. Data Extraction and Synthesis Two researchers extracted study data for attendance, dropout, and clinical outcomes independently. Both assessed the risk of bias according to the Cochrane tool. Data were pooled using random-effects meta-analyses. Main Outcomes and Measures The following 7 outcomes were examined: attendance, dropout, therapeutic alliance, depression and anxiety outcomes, global outcomes, Treatment satisfaction, and remission. Results A total of 7341 articles were identified, with 34 eligible for inclusion. Twenty-nine articles were included in the meta-analyses comprising 5294 participants. Receiving a preferred psychosocial mental health Treatment had a medium positive association with dropout rates (relative risk, 0.62; 0.48-0.80;P  Conclusions and Relevance This is the first review, to our knowledge, examining the association of receiving a preferred psychosocial mental health Treatment with both engagement and outcomes for Patients with a mental health diagnosis. Patients with mental health diagnoses who received their preferred Treatment demonstrated a lower dropout rate from Treatment and higher therapeutic alliance scores. These findings underline the need to accommodate Patient preference in mental health services to maximize Treatment uptake and reduce financial costs of premature dropout and disengagement.

Windle E - One of the best experts on this subject based on the ideXlab platform.

  • Association of Patient Treatment Preference With Dropout and Clinical Outcomes in Adult Psychosocial Mental Health Interventions: A Systematic Review and Meta-analysis.
    'American Medical Association (AMA)', 2019
    Co-Authors: Windle E, Tee H, Sabitova A, Jovanovic N, Priebe S, Carr C
    Abstract:

    Importance: Receiving a preferred Treatment has previously been associated with lower dropout rates and better clinical outcomes, but this scenario has not been investigated specifically for psychosocial interventions for Patients with a mental health diagnosis. Objective: To assess the association of Patient Treatment preference with dropout and clinical outcomes in adult psychosocial mental health interventions via a systematic review and meta-analysis. Data Sources: The Cochrane Library, Embase, PubMed, PsychINFO, Scopus, Web of Science, Nice HDAS (Healthcare Databases Advanced Search), Google Scholar, BASE (Bielefeld Academic Search Engine), Semantic Scholar, and OpenGrey were searched from inception to July 20, 2018, and updated on June 10, 2019. Study Selection: Studies were eligible if they (1) were a randomized clinical trial; (2) involved participants older than 18 years; (3) involved participants with mental health diagnoses; (4) reported data from a group of participants who received their preferred Treatment and a group who received their nonpreferred Treatment or who were not given a choice; and (5) offered at least 1 psychosocial intervention. Data Extraction and Synthesis: Two researchers extracted study data for attendance, dropout, and clinical outcomes independently. Both assessed the risk of bias according to the Cochrane tool. Data were pooled using random-effects meta-analyses. Main Outcomes and Measures: The following 7 outcomes were examined: attendance, dropout, therapeutic alliance, depression and anxiety outcomes, global outcomes, Treatment satisfaction, and remission. Results: A total of 7341 articles were identified, with 34 eligible for inclusion. Twenty-nine articles were included in the meta-analyses comprising 5294 participants. Receiving a preferred psychosocial mental health Treatment had a medium positive association with dropout rates (relative risk, 0.62; 0.48-0.80; P 

Gilles Dumoulin - One of the best experts on this subject based on the ideXlab platform.

  • effects of an in Patient Treatment program based on regular exercise and a balanced diet on high molecular weight adiponectin resistin levels and insulin resistance in adolescents with severe obesity
    Applied Physiology Nutrition and Metabolism, 2012
    Co-Authors: Carine Gueugnon, Fabienne Mougin, M L Simonrigaud, Jacques Regnard, Veronique Negre, Gilles Dumoulin
    Abstract:

    Adiponectin, the most abundant hormone produced by adipose tissue, circulates in 3 isoforms, including high molecular weight (HMW) adiponectin. The latter has been suggested to be a better predictor of metabolic disturbances and insulin resistance associated with obesity. This study investigated changes in total and HMW adiponectin, resistin, and homeostasis model assessment (HOMA) during a 9-month in-Patient Treatment program based on physical exercise and a balanced diet in 32 severely obese adolescents. Total and HMW adiponectin, resistin, and HOMA were measured at baseline (month 0) and during the program (months 3, 6, 9). In addition, a control group of 15 teenagers served as a reference for the baseline assessments. At baseline, HMW adiponectin was more markedly decreased in obese adolescents than total adiponectin, and both were lower than in controls. Conversely, resistin and HOMA were higher in obese adolescents. During the program, there was a significant change in body composition and improved ...

  • effects of an in Patient Treatment program based on regular exercise and a balanced diet on high molecular weight adiponectin resistin levels and insulin resistance in adolescents with severe obesity
    Applied Physiology Nutrition and Metabolism, 2012
    Co-Authors: Carine Gueugnon, Fabienne Mougin, M L Simonrigaud, Jacques Regnard, Veronique Negre, Gilles Dumoulin
    Abstract:

    Adiponectin, the most abundant hormone produced by adipose tissue, circulates in 3 isoforms, including high molecular weight (HMW) adiponectin. The latter has been suggested to be a better predictor of metabolic disturbances and insulin resistance associated with obesity. This study investigated changes in total and HMW adiponectin, resistin, and homeostasis model assessment (HOMA) during a 9-month in-Patient Treatment program based on physical exercise and a balanced diet in 32 severely obese adolescents. Total and HMW adiponectin, resistin, and HOMA were measured at baseline (month 0) and during the program (months 3, 6, 9). In addition, a control group of 15 teenagers served as a reference for the baseline assessments. At baseline, HMW adiponectin was more markedly decreased in obese adolescents than total adiponectin, and both were lower than in controls. Conversely, resistin and HOMA were higher in obese adolescents. During the program, there was a significant change in body composition and improved insulin sensitivity among obese teenagers. In addition, HMW adiponectin and the ratio of HMW-to-total adiponectin increased throughout the study, whereas total adiponectin only increased up until the sixth month. On the contrary, resistin did not show any significant change. In obese adolescents, a long-term combination of aerobic exercise and a balanced diet, inducing change in body composition and improved insulin sensitivity, markedly increased HMW adiponectin compared with total adiponectin, without any change in resistin concentrations. Our results thus suggest that the determination of HMW adiponectin could be more useful than measurement of total adiponectin in clinical settings.